USD 203 Mil as of today(2019-12-15). In depth view into IDEXX Laboratories Total Equity explanation, calculation, historical data and more" />
Market Cap : 21.69 B | Enterprise Value : 22.6 B | P/E (TTM) : 52.47 | P/B : 107.30 |
---|
NAS:IDXX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IDXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
IDEXX Laboratories's total equity for the quarter that ended in Sep. 2019 was USD 203 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Total Equity and Total Liabilities are the two components for Total Assets.
IDEXX Laboratories's Total Equity for the fiscal year that ended in Dec. 2018 is calculated as
Total Equity | = | Total Assets(Q: Dec. 2018 ) | - | Total Liabilities(Q: Dec. 2018 ) |
= | 1537.349 | - | 1546.582 | |
= | -9 |
IDEXX Laboratories's Total Equity for the quarter that ended in Sep. 2019 is calculated as
Total Equity | = | Total Assets(Q: Sep. 2019 ) | - | Total Liabilities(Q: Sep. 2019 ) |
= | 1751.481 | - | 1548.759 | |
= | 203 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline